Fhit–Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells
Authors:
Open Access
- 15 February 2019
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 10 (3) , 1-10
Abstract
Fhit protein is lost in cancers of most, perhaps all, cancer types; when restored, it can induce apoptosis and suppress tumorigenicity, as shown in vitro and in mouse tumor models in vivo. Following protein cross-linking and proteomics analyses, we characterized a Fhit protein complex involved in triggering Fhit-mediated apoptosis. The complex includes the heat-shock chaperonin pair, HSP60/10, which is likely involved in importing Fhit into the mitochondria, where it interacts with ferredoxin reductase, responsible for transferring electrons from NADPH to cytochrome P450 via ferredoxin, in electron transport chain complex III. Overexpression of Fhit protein in Fhit-deficient cancer cells modulates the production of intracellular reactive oxygen species, causing increased ROS, following peroxide treatment, with subsequent increased apoptosis of lung cancer cells under oxidative stress conditions; conversely, Fhit-negative cells escape ROS overproduction and ROS-induced apoptosis, likely carrying oxidative damage. Thus, characterization of Fhit-interacting proteins has identified direct effectors of a Fhit-mediated apoptotic signal pathway that is lost in many cancers. This is of translational interest considering the very recent emphasis in a number of high-profile publications, concerning the role of oxidative phosphorylation in the treatment of human cancers, and especially cancer stem cells that rely upon oxidative phosphorylation for survival. Additionally, we have shown that cells from a Fhit-deficient lung cancer cell line, are sensitive to killing by exposure to atovaquone, thought to act as a selective oxidative phosphorylation inhibitor by targeting the CoQ10 dependence of the mitochondrial complex III, while the Fhit-expressing sister clone is resistant to this treatment.Keywords
Funding Information
- National Cancer Institute (CA – 60047689, CA – 60047689)
- Associazione Italiana per la Ricerca sul Cancro
- National Institute of General Medical Sciences (T32-GM086252)
This publication has 49 references indexed in Scilit:
- Fhit Delocalizes Annexin A4 from Plasma Membrane to Cytosol and Sensitizes Lung Cancer Cells to PaclitaxelPLOS ONE, 2013
- Initiation of Genome Instability and Preneoplastic Processes through Loss of Fhit ExpressionPLOS Genetics, 2012
- Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosisProceedings of the National Academy of Sciences, 2009
- Fhit Modulates the DNA Damage Checkpoint ResponseCancer Research, 2006
- Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IRMolecular Carcinogenesis, 2005
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Cell DeathCell, 2004
- Regression of upper gastric cancer in mice by FHIT gene deliveryThe FASEB Journal, 2003
- The Tumor Suppressor Protein FhitJournal of Biological Chemistry, 1999